COVID-19: Information for pharmacists

We are monitoring stockpiling behaviour and will amend the dispensing rules again if necessary.

Dispensing changes

Read about the latest status of the changes to dispensing

Nominated pharmacy requirement returns for medicines funded under NPPA policy

Now that New Zealand has returned to Level 1, we have reinstated the requirement for patients to use the nominated pharmacy for NPPA medicines. This change is effective as of 8 July 2020.

Sector Operations will process claims

Sector Operations have advised that they will be able to process claims that do not originate from the nominated pharmacy. 

If any pharmacy is concerned about their ability to claim for medicines dispensed and whether or not they are the patient's nominated pharmacy, call the NPPA team on 0800 66 00 50 (option2)

Wastage

We will manage wastage on a case-by-case basis if the patient does not return to the nominated pharmacy.

Lamotrigine exceptional circumstances

Approved lamotrigine exceptional circumstances medication can continue to be dispensed, and claimed for, by any pharmacy.

Approved lamotrigine exceptional circumstances medication can be dispensed, and claimed for, by any pharmacy. It can be dispensed at a dose different to that specified on the approval without notification to, or the approval of, PHARMAC Exceptional Circumstances.  

More information

Medicine supply issues

Changes to access criteria (including Retail Pharmacy – Specialist restrictions)

Your pharmacy and COVID-19 – Health Navigator website(external link)

Who to contact

If you have questions, email us on enquiry@pharmac.govt.nz